Vanguard Global Advisers’s Solid Biosciences SLDB Stock Holding History
Bought
Maintained
Sold
Other funds holding SLDB
SL
Vanguard Global Advisers's SLDB Position: Q3 2026 in Review
Vanguard Global Advisers reduced its Solid Biosciences (SLDB) stake by 11% in Q3 2026, selling an estimated $60.9K and leaving 51,864 shares worth $375K. The position accounts for ﹤0.01% of the portfolio, ranked #2221.
Vanguard Global Advisers first reported a position in SLDB in Q1 2026 and has held it in 3 quarters since. The position peaked at $585K in Q2 2026. 158 funds tracked by Wall St. Rank hold SLDB as of Q3 2026.
- Vanguard Global Advisers held 51,864 shares of Solid Biosciences worth $375K as of Q3 2026.
- Vanguard Global Advisers sold 6,727 Solid Biosciences shares in Q3 2026, an estimated $60.9K.
- Solid Biosciences made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #2221 holding.
- Vanguard Global Advisers first reported a position in Solid Biosciences in Q1 2026 and has held it in 3 quarters since.
- Vanguard Global Advisers's Solid Biosciences position peaked at $585K in Q2 2026.
- 158 funds tracked by Wall St. Rank held Solid Biosciences as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.